| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −19.3× | −7.3× | |
| Price / Book | −13.3× | 3.2× | |
| Price / Sales | 83.1× | 233.4× | |
| Price / Free cash flow | −25.6× | −10.2× | |
| EV / EBITDA | −20.9× | −24.4× | |
| Earnings yield | −5.2% | −9.7% | |
| Free cash flow yield | −3.9% | −0.8% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $18.71 | −4.30% | $1.68B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $32.38 | −3.77% | $1.47B | −418.0× | −38.8% | +1266.2% |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.77 | −3.52% | $727.07M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $13.73 | −7.10% | $626.79M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $13.94 | −6.94% | $443.08M | −7.3× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $14.53 | −9.47% | $215.84M | −149.3× | 157.3% | — |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $2.09 | +2.45% | $37.31M | −5.7× | −16.8% | −56.7% |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.70 | −9.57% | $12.9M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.85 | −6.55% | $2.97M | −0.3× | −65.3% | +95.2% |
